Literature DB >> 10085138

Processing of the fibrillin-1 carboxyl-terminal domain.

T M Ritty1, T Broekelmann, C Tisdale, D M Milewicz, R P Mecham.   

Abstract

To investigate the processing and general properties of the fibrillin-1 carboxyl-terminal domain, three protein expression constructs have been developed as follows: one without the domain, one with the domain, and one with a mutation near the putative proteolytic processing site. The constructs have been expressed in two eukaryotic model systems, baculoviral and CHO-K1. Post-translational modifications that normally occur in fibrillin-1, including glycosylation, signal peptide cleavage, and carboxyl-terminal processing, occur in the three constructs in both cell systems. Amino-terminal sequencing of secreted protein revealed leader sequence processing at two sites, a primary site between Gly-24/Ala-25 and a secondary site of Ala-27/Asn-28. Processing of the carboxyl-terminal domain could be observed by migration differences in SDS-polyacrylamide gel electrophoresis and was evident in both mammalian and insect cells. Immunological identification by Western blotting confirmed the loss of the expected region. The failure of both cell systems to process the mutant construct shows that the multi-basic sequence is the site of proteolytic processing. Cleavage of the fibrillin-1 carboxyl-terminal domain occurred intracellularly in CHO-K1 cells in an early secretory pathway compartment as demonstrated by studies with secretion blocking agents. This finding, taken with the multi-basic nature of the cleavage site and observed calcium sensitivity of cleavage, suggests that the processing enzyme is a secretory pathway resident furin-like protease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085138     DOI: 10.1074/jbc.274.13.8933

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  The microfibrillar proteins MAGP-1 and fibrillin-1 form a ternary complex with the chondroitin sulfate proteoglycan decorin.

Authors:  B C Trask; T M Trask; T Broekelmann; R P Mecham
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  Fibrillin and the eye.

Authors:  J L Ashworth; C M Kielty; D McLeod
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

Review 3.  Fibrillin: from microfibril assembly to biomechanical function.

Authors:  Cay M Kielty; Clair Baldock; David Lee; Matthew J Rock; Jane L Ashworth; C Adrian Shuttleworth
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-02-28       Impact factor: 6.237

4.  N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly.

Authors:  T M Trask; T M Ritty; T Broekelmann; C Tisdale; R P Mecham
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

5.  Profibrillin-1 maturation by human dermal fibroblasts: proteolytic processing and molecular chaperones.

Authors:  Debra D Wallis; Elizabeth A Putnam; Jill S Cretoiu; Sonya G Carmical; Shi-Nian Cao; Gary Thomas; Dianna M Milewicz
Journal:  J Cell Biochem       Date:  2003-10-15       Impact factor: 4.429

Review 6.  Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix.

Authors:  C M Kielty; T J Wess; L Haston; Jane L Ashworth; M J Sherratt; C A Shuttleworth
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

7.  Selective integrin subunit reduction disrupts fibronectin extracellular matrix deposition and fibrillin 1 gene expression.

Authors:  Rajeev K Boregowda; Brooke M Krovic; Timothy M Ritty
Journal:  Mol Cell Biochem       Date:  2012-07-11       Impact factor: 3.396

8.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

Review 9.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

10.  Fibrillin-1 and -2 contain heparin-binding sites important for matrix deposition and that support cell attachment.

Authors:  Timothy M Ritty; Thomas J Broekelmann; Claudio C Werneck; Robert P Mecham
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.